Medicines Patent Pool. Statutes, By-Laws & Policies https://medicinespatentpool.org/who-we-are/statutes-by-laws-policies (8 July 2010).
Medicines Patent Pool. Launch of the Medicines Patent Pool Strategy 2023–2025 https://medicinespatentpool.org/fr/news-publications-post/launch-of-the-medicines-patent-pool-strategy-2023-2025 (13 January 2023).
Schiestl, M. et al. Trends Pharmacol. Sci. 42, 75–84 (2021).
Gore, C., Morin, S., Rottingen, J.-A. & Kieny, M.-P. BMJ Glob. Health 8, e012964 (2023).
Song, C. Duke Law J. 71, 1923 (2021).
Marimuthu, G. et al. Nat. Biotechnol. 30, 50–53 (2012).
Wu, J. & Cheng, C. W. C. Chi-Kent J. Intell. Prop. 19, 93 (2019).
Farlow, A. et al. Vaccines 11, 690–693 (2023).
Fenner, C. et al. Vaccine X 29, 100787 (2026).
Gaviria, M. & Kilic, B. Nat. Biotechnol. 39, 546–548 (2021).
Adekola, T. A. J. Intell. Prop. L. & Pract. 18, 867–877 (2023).
van Overwalle, G. In Research Handbook on Intellectual Property and the Life Sciences 304–334 (Edward Elgar, 2017).
van Zimmeren, E. et al. Trends Biotechnol. 29, 569–576 (2011).
Contreras, J. L. Utah Law Rev. 4, 833 (2021).
Galasso, A. & Schankerman, M. Rev. Econ. Stat. 106, 1529–1541 (2024).
Verbeure, B., van Zimmeren, E., Matthijs, G. & van Overwalle, G. Trends Biotechnol. 24, 115–120 (2006).
Cox, K. L. Hastings Sci. & Tech. Law J. 4, 291 (2012).
Morin, S. et al. Lancet Glob. Health 11, e145–154 (2023).
Shapiro, C. Innov. Policy Econ. 1, 119–150 (2001).
Lerner, J. & Tirole, J. Am. Econ. Rev. 94, 691–711 (2004).
Shukla, A. A., Wolfe, L. S., Mostafa, S. S. & Norman, C. Bioeng. Transl. Med. 2, 58–69 (2017).
Kelley, B., Renshaw, T. & Kamarck, M. Biotechnol. Prog. 37, e3139 (2021).
Burrone, E. In The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development (eds Chon, M. et al.) 93–108 (Cambridge Univ. Press, 2018).
